Short term citrus flavonoid supplementation of type II diabetic women: no effect on lipoprotein oxidation tendencies.
Flavonoids, which are dietary components and have possible drug uses, inhibit lipoprotein oxidation in vitro. The present study considered whether flavonoid supplementation in humans could influence lipoprotein vulnerability to oxidation. Citrus flavonoid supplementation (about 1g/day, 3 weeks), or placebo, was given to 40 Type II diabetic women, a population prone to oxidative stress. Absorbance spectra of plasma from 4 subjects revealed that some flavonoid absorption occurred. When tested in vitro, a supplement extract, with spectrum peak height similar to that of plasma samples, completely inhibited copper-induced oxidation of very low plus low density lipoproteins. In contrast, neither flavonoid supplementation nor placebo influenced lipoprotein susceptibility to copper-stimulated oxidation in vitro (lag time or propagation rate). Thus, this study demonstrated that increased flavonoid consumption by humans does not necessarily alter lipoprotein susceptibility to oxidation assessed in vitro.
Blostein-Fujii
A
A
Department of Human Nutrition & Food Management, The Ohio State University, Columbus 43210, USA.
DiSilvestro
R A
RA
Frid
D
D
Katz
C
C
D000042:Absorption; D000368:Aged; D002957:Citrus / Q000737:chemistry*; D003300:Copper / Q000737:chemistry; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008875:Middle Aged; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010919:Placebos; D017698:Postmenopause; D013053:Spectrophotometry
D005419:Flavonoids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010919:Placebos; C099252:oxidized low density lipoprotein; D003300:Copper